retatrutide dosage phase 2 trial I get this question pretty often now: How do I dose to minimize side effects? I asked participants and long-time users, and I reassembled what I think the official Retatrutide Dosing: Early Clinical Trial

Oz in the release

Clin Drug Investig 40(8):695713

Currently, retatrutide has not been approved by the FDA as it is still in clinical phase 3 trials

And, GLP-1(7-36)amide significantly prevented LPS-, IL-1-, H2O2-induced impairment in synaptic functions of hippocampal CA1 region (219)

External resources Anorgasmia following initiation of GLP-1 agonist, PMC Case Report International Society for Sexual Medicine, GLP-1 Agonists and Sexuality GLP-1 Receptor Agonists, Compulsive Behavior, and Libido, PMC Research GLP-1 Agonist Weight Loss Medications and Sexual Desire, Journal of Sexual Medicine For researchers committed to understanding the full picture of how GLP-1 medications affect female health, SeekPeptides provides evidence-based protocols, comprehensive guides, and a community of knowledgeable researchers navigating these exact questions with the depth and nuance they deserve

However, evidence supporting its efficacy is limited, and it may lead to an undesirable increase in blood pressure